India: Sun Pharma to sell its US manufacturing units to Frontida BioPharm

India: Sun Pharma to sell its US manufacturing units to Frontida BioPharm

Photo: Mint

Sun Pharmaceutical Industries Ltd, India’s largest drug maker, will sell its two oral solid dosage manufacturing facilities located at Philadelphia and Aurora in the US along with 15 related pharmaceutical products to Frontida BioPharm Inc. for an undisclosed amount.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter